$SIBN

SI-BONE, Inc. (SIBN): Entry into a Material Definitive Agreement

SI-BONE, Inc. (SIBN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. sibn-20260604 0001459839 false 0001459839 2026-06-04 2026-06-04 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________ FORM 8-K __________________________________________________________

Original reporting
Published Jun 8, 2026, 8:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 9, 2026, 8:47 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$SIBN
Neutral
medium confidence
Mentioned
$SIBN
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SIBNNeutralLow
01

Why it matters

The only new economic detail is the one-month extension of the company’s HQ office lease at a specified base rent, plus continued operating expense/tax sharing through the expiration date.

02

Market read

This is a routine corporate contract disclosure; it may slightly affect near-term cash/obligations but does not introduce earnings, financing, or strategic catalysts.

03

What to watch

Traders may over-weight the “material definitive agreement” label; the disclosed economics are small and short-dated, so the market impact should be limited unless additional obligations are revealed in the exhibit.

Relevance 6/10Novelty 4/10Timing: after-hours / next-session read-through from an 8-K lease extension

Background

The article is an SEC Form 8-K reporting entry into a material definitive agreement (a lease amendment) and summarizing annual meeting voting results.

Company-level read

Ticker impact

$SIBNNeutralMedium confidence
Context

SI-BONE disclosed a Third Lease Amendment extending its Santa Clara HQ lease for one month (Aug 1–Aug 31, 2026) at $43,696/month.

Expected impact

Low likelihood of a sustained price move; any reaction should be limited to minor balance-sheet/cash-flow optics.

Evidence & confidence

The filing is a routine corporate/contract update with modest, short-duration financial terms and no guidance, financing, or operational milestone.

Market effects

Minimal; office lease terms are company-specific and not indicative of broader medtech/healthcare demand.

None; Santa Clara office occupancy is not a market-wide signal.

None.

Counterpoint

The lease extension could signal short-term planning constraints (e.g., relocation timing), but the one-month term and optional extension suggest flexibility rather than distress.

Key entities

  • SI-BONE, Inc.

    Nasdaq-listed company filing the 8-K; entered into a Third Lease Amendment for its Santa Clara headquarters.

  • BIXBY SPE FINANCE 11, LLC

    Landlord under the amended office lease agreement.

Related articles

$SIBNHigh

SI-BONE, Inc. (SIBN): Results of Operations and Financial Condition

SI-BONE, Inc. (SIBN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991_q226earningsrel.htm EX-99.1 Document Exhibit 99.1 SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Q

$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.

$AAPLMed

Trump Tariff Refunds Just Topped $100 Billion, and These Companies Are Receiving Some of the Largest Checks

The U.S. Supreme Court invalidated Trump IEEPA tariffs, leaving the administration to refund about $166 billion. By Aug. 4, refunds exceeded $100 billion. Apple received $2.19 billion, Amazon $600 million, and others including Walmart ($2.4B), Ford ($1.3B), GM ($500M), and Costco (~$2B) are expected to receive large checks. New Section 301 tariffs may affect prices.